Previous Article | Next Article ![]()
Journal of Virology, September 2001, p. 8781-8791, Vol. 75, No. 18
Max-Planck-Institut für Immunbiologie,
79108 Freiburg,1 Institut für
Pathologie2 and Institute of Medical
Microbiology and Hygiene, Department of Immunology,4
Universität Freiburg, 79104 Freiburg, Institut
für Medizinische Mikrobiologie, Immunologie und Hygiene, 50935 Cologne,3 Medizinische
Universitätsklinik, Abteilung II, 79106 Freiburg,5 and Institut für
Immunologie der Universität Heidelberg, 69120 Heidelberg,6 Germany, and Division of
Immunology and Cell Biology, John Curtin School of Medical Research,
Australian National University, Canberra, Australian Capital
Territory 2601, Australia7
Received 22 March 2001/Accepted 11 June 2001
Cytotoxic T lymphocytes (CTL) play a major role in the recovery
from primary viral infections and the accompanying tissue injuries.
However, it is unclear to what extent the two main cytolytic pathways,
perforin-granzyme A and B exocytosis and Fas ligand (FasL)-Fas
interaction, contribute to these processes. Here we have employed mouse
strains with either spontaneous mutations or targeted gene defects in
one or more components of either of the two cytolytic pathways to
analyze the molecular basis of viral clearance and induction of
hepatitis during lymphocytic choriomeningitis virus infection. Our
results reveal that viral clearance is solely dependent on perforin but
that virus-induced liver damage only occurs when both the FasL/Fas and
the perforin pathways, including granzymes A and B, are simultaneously
activated. The finding that development of hepatitis but not viral
clearance is dependent on the concomitant activation of FasL-Fas and
perforin-granzymes may be helpful in designing novel strategies to
prevent hepatic failures during viral infections.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.18.8781-8791.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Concerted Action of the FasL/Fas and
Perforin/Granzyme A and B Pathways Is Mandatory for the Development of
Early Viral Hepatitis but Not for Recovery from Viral
Infection
*
Corresponding author. Mailing address: Max
Plank-Institut für Immunbiologie, Stübeweg 51, 79108 Freiburg, Germany. Phone: 49 761/5108-533. Fax: 49 761/5108-529.
E-mail: simon{at}immunbio.mpg.de.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|